Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 52, 4885-4889, September 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinués, B.
Right arrow Articles by Bartolomé, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinués, B.
Right arrow Articles by Bartolomé, M.

Urinary Mutagenicity and N-Acetylation Phenotype in Textile Industry Workers Exposed to Arylamines1

B. Sinués2, J. Pérez, M. L. Bernal, M. A. Sáenz, J. Lanuza and M. Bartolomé

Department of Pharmacology, Medical School, University of Zaragoza, Spain

Primary aromatic amines have been identified epidemiologically as human carcinogens. It has been suggested that the target organ affected by aromatic amines is dependent on the rate of metabolic activation. Epidemiological studies have shown an association between low acetyl transferase activity and bladder cancer risk. On this basis, our working hypothesis was that the slow acetylators could follow in a higher extent the metabolic pathway independent of N-acetylation, leading to the excretion of conjugates of electrophyles with glucuronic acid. The instability of these glucuronides could be responsible for the association between arylamine-induced bladder cancer and slow acetylator phenotype. A total of 153 individuals were included in this study: 70 exposed to arylamines (working in textile industry) and 83 nonexposed. The following parameters were determined in urine: mutagenic index in the absence of metabolic activation, S9; mutagenic index in the presence of S9; and the mutagenic index after incubation of the urine with ß-glucuronidase. All individuals were phenotyped according to their capacity of N-acetylation by using isoniazid as drug test. The results show that the mutagenic index after incubation of the urine with ß-glucuronidase is statistically higher in exposed subjects when compared with nonexposed individuals (P < 0.001), this parameter being statistically higher among exposed subjects who were slow acetylators than among rapid metabolizers, independent of the fact that they were smokers or nonsmokers. There were no significant differences between groups for the mutagenicity in urine not incubated with ß-glucuronidase.

1 This work was supported by grants of CONAI of the Diputación General de Aragón, PCM-5/89 (to B.S.).

2 To whom requests for reprints should be addressed, at Departamento de Farmacologia, C/Domingo Miral s/n, 50009, Zaragoza, Spain.

Received 10/21/91. Accepted 7/ 2/92.




This article has been cited by other articles:


Home page
Occup. Environ. Med.Home page
R Vermeulen, R P Bos, J Pertijs, and H Kromhout
Exposure related mutagens in urine of rubber workers associated with inhalable particulate and dermal exposure
Occup. Environ. Med., February 1, 2003; 60(2): 97 - 103.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Pavanello, P. Simioli, S. Lupi, P. Gregorio, and E. Clonfero
Exposure Levels and Cytochrome P450 1A2 Activity, but not N-Acetyltransferase, Glutathione S-Transferase (GST) M1 and T1, Influence Urinary Mutagen Excretion in Smokers
Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 998 - 1003.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
B. Sinués, M. A. Sáenz, J. Lanuza, M. L. Bernal, A. Fanlo, J. L. Juste, and E. Mayayo
Five Caffeine Metabolite Ratios to Measure Tobacco-induced CYP1A2 Activity and Their Relationships with Urinary Mutagenicity and Urine Flow
Cancer Epidemiol. Biomarkers Prev., February 1, 1999; 8(2): 159 - 166.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1992 by the American Association for Cancer Research.